h1 bulletSymptomatic Reversal of Peripheral Neuropathy in Patients with Diabetes



Alan B. Kochman, MSPT*, Dale H. Carnegie, DPM{dagger} and Thomas J. Burke, PhD{ddagger}

* Lead Therapist, The Medical Center of Aurora, Aurora, CO.
{dagger} Chief of Podiatric Services, Department of Orthopedics, Denver Health Medical Center, Denver, CO.
{ddagger} President, Integrated Systems Physiology Inc, 12635 Montview Blvd, Suite 216, Aurora, CO 80010.



Forty-nine consecutive subjects with established diabetic peripheral neuropathy were treated with monochromatic near-infrared photo energy (MIRE) to determine if there was an improvement of sensation. Loss of protective sensation characterized by Semmes-Weinstein monofilament values of 4.56 and above was present in 100% of subjects (range, 4.56 to 6.45), and 42 subjects (86%) had Semmes-Weinstein values of 5.07 or higher. The ability to discriminate between hot and cold sensation was absent (54%) or impaired (46%) in both groups prior to the initiation of MIRE treatment. On the basis of Semmes-Weinstein monofilament values, 48 subjects (98%) exhibited improved sensation after 6 treatments, and all subjects had improved sensation after 12 treatments. Therefore, MIRE may be a safe, drug-free, noninvasive treatment for the consistent and predictable improvement of sensation in diabetic patients with peripheral neuropathy of the feet. (J Am Podiatr Med Assoc 92(3): 125-130, 2002)